ERBB3 and neoplasm: Another key finding identified in this report explains a feature of PI3kinase signaling inhibition that has been observed in several tumor models but not well understood, namely the lack of observed efficacy of ErbB3 inhibition in vitro relative to the profound anti-tumor effect in vivo.